Antithrombosis Trials: Should we test therapeutic heparin adjusted based on activated partial thromboplastin time in septic shock?
Crit Care Med
.
2009 Apr;37(4):1486-7.
doi: 10.1097/CCM.0b013e31819d2bb4.
Authors
Amisha V Barochia
,
Yan Li
,
Xizhong Cui
,
Daniel A Sweeney
,
Charles Natanson
,
Peter Q Eichacker
PMID:
19318828
PMCID:
PMC3383779
DOI:
10.1097/CCM.0b013e31819d2bb4
No abstract available
Publication types
Comment
Editorial
MeSH terms
Anticoagulants / administration & dosage*
Heparin / administration & dosage*
Humans
Partial Thromboplastin Time*
Shock, Septic / blood*
Shock, Septic / drug therapy*
Substances
Anticoagulants
Heparin
Grants and funding
Z99 CL999999/ImNIH/Intramural NIH HHS/United States